2 July 2018
Appointment of Directors
Adelaide, Australia, 2 July 2018 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in medical devices for the diagnosis and treatment of eye disease, today announced the appointment of two new Directors to the Board, Mr. Mike Southard and Mr. Mike Mangano. The appointment will be ratified, by resolution, at the company’s next AGM.
Mike Southard spent 25 years with the world’s largest ophthalmology company, Alcon Laboratories of Fort Worth Texas, as Vice President of the Global Surgical business. During Mike’s tenure, the Alcon business grew dramatically from US$85 million to US$2.4 billion of sales per year. Prior to this, he was an executive with Beecham Laboratories (now SmithKline Beecham), and Cooper-Vision, which was acquired by Alcon Laboratories.
Mike is currently actively involved in Ophthalmology, Dermatology and Orthopaedics through his consulting company based in Portland, Oregon, USA. He has vast experience in both the International and U.S. markets and maintains important contacts with many of the world’s key opinion leaders in all areas of eye surgery.
Mike holds a Bachelor of Science Degree from Oregon State University, in Business, and also an executive MBA degree from Stanford University. Mike has served on Scientific Advisory Boards, Industry Advisory Councils, and also represented the International Markets and the Eye Surgery segment on the team that lead the initial public offering of Alcon in the early 2000’s.
Mike Mangano is an accomplished global executive leader with over 23 years’ experience in the medical device industry.
He was most recently the President and CEO of ReShape Medical Inc., a U.S. venture backed company focused on obesity that was sold in October of 2017. Prior to ReShape, he was President of the Americas for Sirtex Medical for over six years. At Sirtex Mike grew the business from US$30 million to over US$140 million of sales per year, while building a team of 17 to more than 130 employees. Prior to Sirtex, he spent 15 years with Boston Scientific in numerous senior executive roles, including two overseas positions in Japan and Australia. He has vast experience in sales and marketing management, product development, strategic planning, international business, M&A, project management, and business model development. He currently is a member of the board of directors of ABK Biomedical.
Commenting on the appointments, Ellex Chairman, Mr Victor Previn stated: “Mike Southard’s successful career in sales and marketing with global ophthalmic company Alcon will provide us with valuable insights and inputs as to how best to grow our company. Mike Mangano’s track record with Sirtex in the U.S. medical device industry will serve us well as we seek to target rapid sales growth in the USA. We are delighted to welcome these exceptional business leaders to the Ellex Board.”
Ellex designs, develops, manufactures and sells innovative products that help eye surgeons around the world to effectively and efficiently treat eye disease. Ellex is a world leader in this field. Headquartered in Adelaide, Australia, Ellex has ophthalmic lasers and devices that treat glaucoma, retinal disease primarily caused by diabetes, secondary cataract and vitreous opacities, as well as age-related macular degeneration. Manufacturing is carried out in Adelaide, Australia and Fremont, California. Sales and service directly to eye surgeons is conducted via subsidiary offices in Fremont, Minneapolis, Lyon, Berlin and Tokyo. A network of more than 50 distribution partners around the world services other markets.
For additional information about Ellex and its products, please visit www.ellex.com
|For further information on Ellex please contact: Tom Spurling, CEO
W +1 510 291 1301
USA M +1 510 504 1267
AUS M +61 417 818 658
|Mark Lindh, Investor Relations & Corporate
W +61 8 87074 8200 | M +61 414 551 email@example.com
|Maria Maieli, CFO & Company Secretary
W +61 8 7074 8200